|Last Price$140.43||Day Change (%)2.65%|
|Open Price$138.24||Day Change ($)3.63|
|Day Range137.56–140.44||52-Week Range105.21–142.56|
As of Thu 12/18/2014 06:34 PM EST | USD
Aethon and BD Announce Collaboration to Develop Integrated Medication Management Solution
Research and Markets: Canada Diabetes Management Devices Market Assessment and Forecast To 2019
BD to Present at the 26th Annual Piper Jaffray Healthcare Conference
Hello, and welcome to BD's Second Fiscal Quarter 2014 Earnings Call. At the request of BD, today's call is being recorded. It will be available for replay through May 8, 2014, on the Investors page of the bd.com website or by phone at 800-585-8967 for domestic calls and area code 404-537-3406 for ...
This screen finds companies ready to take advantage when major provisions of law take effect in 2014.
Research and Markets: 2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers
Four offerings deemed to be right for right now.
Research and Markets: Novel Drug Reconstitution Systems: Industry Partnerships and Technological Evolution, 2014 - 2024
KaloBios Elects Robert A. Baffi, BioMarin Senior Executive, to Board of Directors
UPDATE: Millennial employment, mini baby boom could lift 2015 home sales